Finch Therapeutics Group, Inc. (FNCH)
Largest Insider Buys in Sector
FNCH Stock Price History Chart
FNCH Stock Performance
About Finch Therapeutics Group, Inc.
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides difficile infection, as well as for the treatment of chronic hepatitis B virus. It is also developing FIN-211, an orally administered enriched consortia product candidate for use in the treatment of autism …
Insider Activity of Finch Therapeutics Group, Inc.
Over the last 12 months, insiders at Finch Therapeutics Group, Inc. have bought $0 and sold $21,246 worth of Finch Therapeutics Group, Inc. stock.
On average, over the past 5 years, insiders at Finch Therapeutics Group, Inc. have bought $15.7M and sold $12,820 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 5,010 shares for transaction amount of $1,353 was made by Graf Susan E (director) on 2023‑06‑09.
List of Insider Buy and Sell Transactions, Finch Therapeutics Group, Inc.
| 2024-03-28 | Sale | director | 8,242 0.5089% | $2.58 | $21,246 | +60.77% | ||
| 2023-11-22 | Sale | director | 1,470 0.0901% | $3.64 | $5,351 | -24.59% | ||
| 2023-06-09 | director | 5,010 0.0003% | $0.27 | $1,353 | -54.61% | |||
| 2023-02-21 | Sale | Chief Operating Officer | 4,619 0.0097% | $0.38 | $1,755 | +29014.17% | ||
| 2022-10-21 | Sale | Chief Operating Officer | 3,636 0.0078% | $1.39 | $5,054 | -32.44% | ||
| 2022-10-21 | Sale | Chief Business & Legal Officer | 3,636 0.0078% | $1.39 | $5,054 | -32.44% | ||
| 2021-12-20 | director | 63,850 0.1713% | $10.18 | $649,993 | -73.92% | |||
| 2021-03-23 | 735,294 5.3498% | $17.00 | $12.5M | -19.16% | ||||
| 2021-03-23 | director | 88,235 0.642% | $17.00 | $1.5M | -19.16% | |||
| 2021-03-23 | director | 882,351 6.4197% | $17.00 | $15M | -19.16% | |||
| 2021-03-23 | director | 102,941 0.749% | $17.00 | $1.75M | -19.16% |
Insider Historical Profitability
| SMISEK JEFFERY A | director | 0 0% | $10.80 | 1 | 2 | <0.0001% |
| Crestovo Investor LLC | 12641441 787.2559% | $10.80 | 1 | 0 | <0.0001% | |
| Haft Nicholas | director | 4056907 252.6472% | $10.80 | 2 | 0 | <0.0001% |
| FERRANTE DOMENIC J | director | 636195 39.6196% | $10.80 | 1 | 0 | <0.0001% |
| Graf Susan E | director | 5010 0.312% | $10.80 | 1 | 0 | <0.0001% |